Group leader @CNR and @Humanitas. Basic and Translational #CardiovascularResearch x novel #TherapeuticApproaches #Nanoparticle #DrugDelivery #CUPIDO_project
Milan, MI
Joined April 2013
- Tweets757
- Following1K
- Followers361
- Likes768
A research position is available within a funded PRIN 2022 PNRR project entitled “A Chaperone Network Shapes Heart Resilience During Stress and Aging.” Join us to investigate the molecular mechanisms underlying chaperone protection in cardiac aging.
jobrxiv.org/job/national-res…
Daniele Catalucci retweeted
DZHK Paper of the Month | Feb 2024 🥁🏆
From the 🫁 to the 🫀: Read about a novel peptide-based inhalation therapeutic for the treatment of #HeartFailure Congratulations to Alessio Alogna @dhzcharite & his team
tinyurl.com/yws8zue3
#CardioTwitter
Daniele Catalucci retweeted
Prosegue la sperimentazione dell'innovativa formulazione inalatoria per il trattamento delle malattie cardiache messa a punto nell’ambito del @cupido_project. I risultati sono descritti da uno studio coordinato da #Cnr_Irgb e @ChariteBerlin
👇
cnr.it/it/nota-stampa/n-1244…
@MC_Carro
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances genscript.com/index.php/refe… @GenScript
Discovering #NanoPhoria, a cutting-edge and brand-new startup developing a revolutionary and promising #HeartFailure inhalation treatment. Claudio De Luca, our CEO, explains how. Spoiler alert: it's done by a non-viral, biomimetic nanocarrier technology.
linkedin.com/posts/nanophori…
Daniele Catalucci retweeted
Sofinnova Partners Announces New Investment In Nanophoria, Developer Of An Innovative Non-viral Drug Delivery Platfo crweworld.com/article/news-p…
Daniele Catalucci retweeted
La startup biotech NanoPhoria incassa un round 3,5 milioni dlvr.it/SQRy3M
Daniele Catalucci retweeted
NanoPhoria, società spin-off del #Cnr, ha ricevuto un investimento di 3,5milioni € da parte di @SofinnovaVC, una delle principali società europee di venture capital nel settore delle scienze della vita.
La società sarà presentata oggi a #Bioequity Milano
cnr.it/it/news/11112
We are pleased to welcome NanoPhoria to our portfolio via a €3.5 million seed investment that will advance its pre-clinical stage treatment for heart failure. #biotech
hubs.ly/Q01bb_ms0
ALT We are pleased to welcome NanoPhoria to our portfolio via a €3.5 million seed investment.
Daniele Catalucci retweeted
In its eighth disclosed investment from its Italy-focused Telethon fund, @SofinnovaVC has backed non-viral delivery company NanoPhoria with a €3.5M seed investment buff.ly/3PdKeiZ
Daniele Catalucci retweeted
We are pleased to welcome NanoPhoria to our portfolio via a €3.5 million seed investment that will advance its pre-clinical stage treatment for heart failure. #biotech
hubs.ly/Q01bb_ms0
ALT We are pleased to welcome NanoPhoria to our portfolio via a €3.5 million seed investment.
National Research Council (CNR) Institute of Genetic and Biomedical Research (IRGB) is #hiring a Research Position (either a junior or post- doctoral fellow)! #openposition jobs.escardio.org/research-p…
Daniele Catalucci retweeted
at the TecMedLab @UNIPR in collaboration with @CNRsocial_ and @HumanitasMilano we growth SiC semiconductive nanowires to reinstate impulse propagation in 5 hrs after myocardial infarction. See our work published on @NatureComms.
rdcu.be/cEGsL
A #research_position is #available for either a junior or post-doctoral fellow. #Nanotherapeutic approaches for #COVID19 and #HeartFailure
#Milan #job #research #fellowship
humanitas-research.org/group… irgb.cnr.it/people-4-3-2/dan…
Daniele Catalucci retweeted
#ResearchLetter MicroRNA therapeutics in cardiology is limited by invasive administration. @DCatalucci et al. demonstrate a proof-of-concept inhalable nanoparticle microRNA delivery mechanism @CNRsocial_ @HumanitasMilano ahajournals.org/doi/10.1161/…
Nano-miR-133a Replacement #Therapy Blunts Pressure Overload–Induced #HeartFailure #DrugDelivery #cardio #ncRNA #microRNA #inhalation @cupido_project @EU_Commission ahajournals.org/doi/10.1161/…
Daniele Catalucci retweeted
Nano- and Micro-carrier Based #Cardiovascular Drug Delivery. A new Research Topic @FrontDrugDDS has been lunched
frontiersin.org/research-top…
#DrugDelivery, #DrugDiscovery, #nano #micro #DrugSafety
#Research Topic
The Role of Circulating Immune Mediators in the Crosstalk Between Cells of the Immune System and Cardiovascular Systems in CVDs @FrontImmunol frontiersin.org/research-top…
Daniele Catalucci retweeted
Another awesome result for one of our partners! Eride Quarta from @PlumeStars got awarded the @eufeps Women In Pharmaceutical Sciences Awards 2021 with her talk on inhalable microparticles developed within CUPIDO. Well deserved 👏👩🔬 #nanomedicine #WomenInSTEM
Daniele Catalucci retweeted
Congrats to our partner Lorenzo Degli Esposti, who won the Special Prize Elena Benaduce 🏅by @GiovediScienza for #scicomm! Very proud of you to bring on the legacy of CUPIDO and #nanomedicine 🙌🎉
